Adaptive Biotechnologies ADPT Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's total liabilities?
- Adaptive Biotechnologies (ADPT) reported total liabilities of $281.7M in Q1 2026.
- How has Adaptive Biotechnologies's total liabilities changed year-over-year?
- Adaptive Biotechnologies's total liabilities decreased by 12.1% year-over-year, from $320.63M to $281.7M.
- What is the long-term trend for Adaptive Biotechnologies's total liabilities?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's total liabilities has grown at a -5.1% compound annual growth rate (CAGR), from $373.15M to $287.74M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.